BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20427349)

  • 1. Survival differences among women with de novo stage IV and relapsed breast cancer.
    Dawood S; Broglio K; Ensor J; Hortobagyi GN; Giordano SH
    Ann Oncol; 2010 Nov; 21(11):2169-2174. PubMed ID: 20427349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of outcomes between women with de novo stage IV and relapsed breast cancer.
    Kitagawa D; Horiguchi S; Yamashita T; Kuroi K; Shimizu K
    J Nippon Med Sch; 2014; 81(3):139-47. PubMed ID: 24998960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed.
    den Brok WD; Speers CH; Gondara L; Baxter E; Tyldesley SK; Lohrisch CA
    Breast Cancer Res Treat; 2017 Feb; 161(3):549-556. PubMed ID: 28000014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
    Press DJ; Miller ME; Liederbach E; Yao K; Huo D
    Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of survival time of breast cancer in kurdistan province of Iran between 2006-2014: a cox regression approach.
    Karimi A; Delpisheh A; Sayehmiri K; Saboori H; Rahimi E
    Asian Pac J Cancer Prev; 2014; 15(19):8483-8. PubMed ID: 25339051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
    Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and metastatic behavior between de novo versus recurrent HER2-positive metastatic breast cancer: A 17-year single-institution cohort study at Taipei Veterans General Hospital.
    Cheng HF; Tsai YF; Huang CC; Lien PJ; Wang YL; Hsu CY; Chen YJ; Liu CY; Chao TC; Lin YS; Feng CJ; Chiu JH; Chau GY; Tseng LM
    J Chin Med Assoc; 2022 Jan; 85(1):88-94. PubMed ID: 34561409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
    Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.
    Christopherson K; Lei X; Barcenas C; Buchholz TA; Garg N; Hoffman KE; Kuerer HM; Mittendorf E; Perkins G; Shaitelman SF; Smith GL; Stauder M; Strom EA; Tereffe W; Woodward WA; Smith BD
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):574-581. PubMed ID: 30851348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
    Gu Y; Wu G; Zou X; Huang P; Yi L
    Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
    Klar N; Rosenzweig M; Diergaarde B; Brufsky A
    Clin Breast Cancer; 2019 Aug; 19(4):304-310. PubMed ID: 30827763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Difference in Prognostic Outcomes Between
    Yamamura J; Kamigaki S; Fujita J; Osato H; Komoike Y
    In Vivo; 2018; 32(2):353-358. PubMed ID: 29475920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
    PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
    Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
    Wang K; Shi Y; Li ZY; Xiao YL; Li J; Zhang X; Li HY
    Eur J Surg Oncol; 2019 Aug; 45(8):1364-1372. PubMed ID: 30837102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer.
    Dawood S; Lei X; Litton JK; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM
    Cancer; 2012 Oct; 118(19):4652-9. PubMed ID: 22359359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life.
    Si Y; Yuan P; Hu N; Wang X; Ju J; Wang J; Ma F; Luo Y; Zhang P; Li Q; Xu B
    Ann Surg Oncol; 2020 Apr; 27(4):1025-1033. PubMed ID: 31970572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.